AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.

MLA

Mammeri, Hedi, et al. “AmpC Beta-Lactamase in an Escherichia Coli Clinical Isolate Confers Resistance to Expanded-Spectrum Cephalosporins.” Antimicrobial Agents and Chemotherapy, vol. 48, no. 10, Oct. 2004, pp. 4050–53. EBSCOhost, https://doi.org/10.1128/AAC.48.10.4050-4053.2004.

APA

Mammeri, H., Nazic, H., Naas, T., Poirel, L., Léotard, S., & Nordmann, P. (2004). AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy, 48(10), 4050–4053. https://doi.org/10.1128/AAC.48.10.4050-4053.2004

Chicago

Mammeri, Hedi, Hasan Nazic, Thierry Naas, Laurent Poirel, Sophie Léotard, and Patrice Nordmann. 2004. “AmpC Beta-Lactamase in an Escherichia Coli Clinical Isolate Confers Resistance to Expanded-Spectrum Cephalosporins.” Antimicrobial Agents and Chemotherapy 48 (10): 4050–53. doi:10.1128/AAC.48.10.4050-4053.2004.